Surveillance Cohort Long-term Toxicity Antiretrovirals in HIV-infected Patients Enrolled in TPV Cohort

SCOLTA: SURVEILLANCE COHORT LONG-TERM TOXICITY ANTIRETROVIRALS

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00805857

Enrollment

Registered

2008-12-10

Start date

2008-06-30

Completion date

Unknown

Last updated

2018-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Brief summary

The SCOLTA project is a system for online surveying of adverse events to recently commercialized antiretroviral drugs and a sentinel for unexpected and late adverse events reactions arising during any antiretroviral treatment.Aim of the proposed study is: 1. to evaluate the prevalence and incidence of serious adverse events and serious unexpected adverse events in HIV-infected patients enrolled in the SCOLTA project Tipranavir cohort and to identify possible risk factors 2. the evaluation of tipranavir containing regimens durability, considering treatment interruption for each reason.

Interventions

DRUGTipranavir

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* All patients \> 18 years old HIV infected treated with tipranavir

Design outcomes

Primary

Measure	Time frame
To evaluate the prevalence and incidence of serious adverse events and serious unexpected adverse events in HIV infected patients enrolled in Tipranavir cohort and to identify possible risk factors	48wks

Secondary

Measure	Time frame
the evaluation of tipranavir containing regimens durability, considering treatment interruption for each reason	48wks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026